Etoricoxib | compare suppliers & send inquiries for free
Looking for Etoricoxib 202409-33-4?
- API | Excipient name:
- Etoricoxib
- Synonyms:
- ETORICOXIB, Etoricoxibum
- Cas Number:
- 202409-33-4
- DrugBank number:
- DB01628
- Unique Ingredient Identifier:
- WRX4NFY03R
About Etoricoxib
You can find a short description about Etoricoxib here. Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins (PGs) from arachidonic acid. It is approved in more than 60 countries worldwide but not in the US.
Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements
Etoricoxib manufacturers | traders | suppliers
We have 17 companies offering Etoricoxib from 4 different countries.
Get in contact with the supplier of your choice:
- TIEFENBACHER API + Ingredients from Germany
- HEER PHARMA PVT. LTD. from India
- Erregierre from Italy
- Kores from India
- Mylan from India
- Fabbrica Italiana Sintetici (FIS) from Italy
- Hetero Labs from India
- Alembic Pharma from India
- Glenmark Pharma from India
- GVK Biosciences Pvt Ltd from India
- Cadila Healthcare from India
- Pharmazell from Germany
- Punjab Chemicals & Crop from India
- Assurgen Pharma from India
- KRKA from Slovenia
- Humble Healthcaare from India
- Sai-Tech Pharmaceuticals Pvt. Ltd. from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.